| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/20/2006 | WO2006102191A1 Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 03/20/2006 | CA2600175A1 Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 03/17/2006 | CA2477867A1 Peptides, dna's, rna's, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same |
| 03/16/2006 | WO2006029275A2 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | WO2006029224A2 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | WO2006029146A2 6H-[1]BENZOPYRANO[4,3-b]QUINOLINES AND THEIR USE AS ESTROGENIC AGENTS |
| 03/16/2006 | WO2006028958A2 Pyridyl inhibitors of hedgehog signalling |
| 03/16/2006 | WO2006028226A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | WO2006028197A1 Anti-a33 antibody |
| 03/16/2006 | WO2006028160A1 S-oligonucleotide conjugate and antisense agent |
| 03/16/2006 | WO2006028122A1 Agent for preventing and ameliorating obesity |
| 03/16/2006 | WO2006028110A1 Process for producing water-soluble hyaluronic acid modification |
| 03/16/2006 | WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13 |
| 03/16/2006 | WO2006027365A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 03/16/2006 | WO2006012502A3 Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| 03/16/2006 | WO2005106488A3 Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) |
| 03/16/2006 | WO2005030260A8 Bispecific oligonucleotide for the treatment of cns malignancies |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058541 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof |
| 03/16/2006 | US20060058523 Quinazoline compounds |
| 03/16/2006 | US20060058522 2-[(aminocarbonyl)amino]-5-(4-{[2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophene-3-carboxamide; I kappa B kinase-1(IKK-1) inhibitors; asthma, rheumatoid arthritis, psoriasis, inflammatory bowel disease, multiple sclerosis, chronic obstructive pulmonary disease, bone resorptive disease, osteoarthritis |
| 03/16/2006 | US20060058520 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058398 Medicinal compositions containing vitamin k's as nerve growth factor potentiator and utilization thereof |
| 03/16/2006 | US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |
| 03/16/2006 | US20060058381 Pharmaceutical formulation comprising (r)-bicalitamide |
| 03/16/2006 | US20060058379 Connexin 26 inhibitor and cancer metastasis inhibitors |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058362 7-Amido-isoindolyl compounds and methods of their use |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058325 Therapeutic quniazoline derivatives |
| 03/16/2006 | US20060058324 4-Amino-5-phenyl-7-cyclohexyl-pyrrolo 2,3-d pyrimidine derivatives |
| 03/16/2006 | US20060058318 Prodrugs of an ERK protein kinase inhibitor |
| 03/16/2006 | US20060058313 Treatment of mesothelioma |
| 03/16/2006 | US20060058307 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 03/16/2006 | US20060058306 Solubilized topoisomerase poison agents |
| 03/16/2006 | US20060058305 Antiproliferative agents such as 3-(3-trifluoromethylphenyl)cinnolin-5-ol |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058295 Novel compounds as pharmaceutical agents |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058282 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 03/16/2006 | US20060058270 Ruthenium anticancer complexes |
| 03/16/2006 | US20060058260 Combination therapy with gemcitabine and zd6126 |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060058227 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 03/16/2006 | US20060058226 Gd3-mimetic peptides |
| 03/16/2006 | US20060057714 Vector |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057649 Screening method and anti-tumor drug candidate obtained therefrom |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057628 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 03/16/2006 | US20060057574 Tissue specific expression |
| 03/16/2006 | US20060057237 Extract with anti-tumor and anti-poisonous activity |
| 03/16/2006 | US20060057219 Method for preparing a polymer micelle pharmaceutical preparation containing drug for injection |
| 03/16/2006 | US20060057162 Induction of cytotoxic T-lymphocyte responses |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | US20060057139 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060057136 Immunotherapy of B-Cell malignancies using anti-CD22 antibodies |
| 03/16/2006 | US20060057130 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057113 Novel adenoviruses, nucleic acids coding therefor, and use thereof |
| 03/16/2006 | US20060057099 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/16/2006 | DE10394214T5 Methyl-B-Orcinolcarboxylat aus Flechten (Everniastrum cirrhatum) zur Verwendung für die Behandlung von Pilzinfektionen und Krebs Methyl-B-Orcinolcarboxylat from lichens (Everniastrum cirrhatum) for use in the treatment of fungal infections and cancer |
| 03/16/2006 | DE102004040014A1 New aureonitrile compounds useful as cytostatic agents, fungicides and antibiotics |
| 03/16/2006 | CA2591321A1 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
| 03/16/2006 | CA2583375A1 Regulation of oncogenes by micrornas |
| 03/16/2006 | CA2579886A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | CA2579660A1 Beta-glucuronidase cleavable prodrugs of o6-alkylguanine-dna alkyltransferase inactivators |
| 03/16/2006 | CA2579558A1 Cancer-testis antigens |
| 03/16/2006 | CA2579533A1 Drug delivery from embolic agents |
| 03/16/2006 | CA2579302A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 03/16/2006 | CA2579102A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/16/2006 | CA2578958A1 Acetylated starch or starch succinate for treatment of obesity or diabetes |
| 03/16/2006 | CA2578164A1 6h-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
| 03/16/2006 | CA2578052A1 Methods of activating nkt cells |
| 03/16/2006 | CA2577828A1 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | CA2577823A1 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | CA2575997A1 Carrier conjugates of gnrh-peptides |
| 03/16/2006 | CA2565235A1 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/15/2006 | EP1634949A1 Method for generating activated T-cells and antigen-pulsed antigen-presenting cells |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1634881A1 Harmine derivatives, intermediates used in their preparation, preparation processes and use thereof |
| 03/15/2006 | EP1634874A1 Imidazolidine derivative |
| 03/15/2006 | EP1634601A2 Dietary supplement comprising soyabean, mushroom and mung bean |
| 03/15/2006 | EP1634600A1 Antiallergic composition |
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634498A2 Exo-S-mecamylamine formulation |
| 03/15/2006 | EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 03/15/2006 | EP1633883A1 Method for assaying lkb1 phosphorylation activity |
| 03/15/2006 | EP1633784A2 Ovr110 antibody compositions and methods of use |
| 03/15/2006 | EP1633773A2 D-amino acid peptides |